FDA Extends Deadline For Continuous Marketing Application Pilot 2 Again
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency is accepting applications for the fast-track IND pilot program until Dec. 31. Applications will only be accepted by those divisions of the drug and biologics centers that have not previously selected a Pilot 2 application.